NEW YORK, April 5 (GenomeWeb News) - Affymetrix has licensed a number of patents to
Abbott Molecular, a division of Abbott, the company said today.
The non-exclusive agreement allows Abbott to manufacture and sell comparative genomic hybridization microarrays, readers, and software for research and diagnostics.
Affymetrix did not disclose details of the license.